Sugar reduction and low/no calorie sweeteners in dietary practice

The case of obesity and diabetes

Sponsor logo

Dear Webinar Attendees,

We are delighted to welcome you to this webinar which is organized by the European Federation of the Associations of Dietitians (EFAD) and two of the ESDNs- Diabetes and Obesity- and made possible through the support of the International Sweeteners Association (ISA). Our aim is to empower dietitians with the knowledge that they need to effectively manage people with obesity and diabetes to reduce their sugar intake based on recommendations. During this webinar, our speakers will share their practical insights and research experience relating to the nutritional status and needs of these patients.

This webinar aims to provide all the latest information and research outcomes on the main characteristics of low/no calorie sweeteners and their role in dietary practice. It will clarify the use of low/no calorie sweeteners in foods and drinks and their role in reformulation and in sugar reduction for people with obesity and diabetes, the effect of low/no calorie sweeteners on reducing energy intake and on weight management, the impact of low/no calorie sweeteners on glucose control and therefore their role in the diet of people with diabetes. The speakers will discuss how low/no calorie sweeteners can be part of a healthy diet and will inform us on sugar reduction policies in Europe through a review of effective strategies. Finally, new data from a network meta-analysis on whether substituting sugar with low/no calorie sweeteners can improve cardiometabolic risk will be presented at the webinar.

We hope you will enjoy this webinar and look forward to seeing primary dietitians and other health care professionals attending the webinar. At the end of this webinar you can expect to have gained the following insight:

  1. How low/no calorie sweeteners can help meet public health recommendations about sugar intake reduction and if they are linked to a higher-quality diet.
  2.  What the results of the different sugar reduction policies in Europe are.
  3.  What the balance of evidence from human clinical trials shows about if and how low/no calorie sweeteners can aid weight loss and glucose control, when used as a replacement for sugar. Why is there a controversy between observational studies and randomised controlled trials?
  4.  What new evidence shows about the effect of low/no calorie sweeteners on different cardiometabolic risk factors including adiposity, glycaemic control, blood pressure, blood lipid levels, and liver fat.

With kind regards,

Charilaos Dimosthenopoulos MSc MedSci. SRD. PhDc
Chief Dietitian-Biologist
Dietetic Dept at General Hospital of Athens "Laiko"
Board Member of DNSG & Lead of EFAD European Specialist for Diabetes

Professor Maria Hassapidou,

Department of Nutritional Sciences and Dietetics,
International Hellenic University, Thessaloniki, Greece,
Chair of ESDN Obesity, EFAD
Chair of NWG, EASO